Research Topics
| Jeffrey S BergerSummaryAffiliation: Duke University Medical Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysisJeffrey S Berger
Duke Clinical Research Institute, Durham, NC 27710, USA
Am J Med 121:43-9. 2008..Our objective was to evaluate the benefit and risk of low-dose aspirin (50-325 mg/d) in patients with stable cardiovascular disease...
Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapyJeffrey S Berger
Duke Clinical Research Institute, Durham, NC, USA
Circulation 117:192-9. 2008..We therefore compared the acute mortality and bleeding risks associated with the initial use of 162 versus 325 mg aspirin in fibrinolytic-treated ST-elevation myocardial infarction patients...- Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysisJeffrey S Berger
Division of Cardiology, Duke University School of Medicine, Duke Clinical Research Institute, Durham, North Carolina 27705, USA
J Am Coll Cardiol 52:1693-701. 2008..S. hospitals... - Vascular disease burden and in-hospital outcomes among patients undergoing percutaneous coronary intervention in New York StateJeffrey S Berger
Division of Cardiovascular Medicine, Department of Medicine, Duke University Medical Center, Durham, NC, USA
Circ Cardiovasc Interv 2:317-22. 2009..However, there is little data regarding the impact of the presence and extent of vascular disease on outcomes in patients with CAD undergoing percutaneous coronary intervention... - Representation of women in randomized clinical trials of cardiovascular disease preventionChiara Melloni
Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
Circ Cardiovasc Qual Outcomes 3:135-42. 2010.... - Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trialsJeffrey S Berger
Department of Cardiovascular Medicine, Duke University, Durham, NC, USA
JAMA 295:306-13. 2006..Aspirin significantly increased the risk of bleeding to a similar degree among women and men... - Early sustained ventricular arrhythmias complicating acute myocardial infarctionJonathan P Piccini
Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
Am J Med 121:797-804. 2008..The objective of this analysis was to identify predictors of sustained ventricular arrhythmias after acute MI and to determine the influence of successful revascularization on in-hospital mortality... - Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early RapJeffrey S Berger
Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
Am Heart J 158:998-1004.e1. 2009..We examined the safety and tolerability of a novel, direct-acting, reversible, intravenous P2Y12 ADP-receptor antagonist, elinogrel, versus placebo when administered to STEMI patients before primary PCI... - Gender-age interaction in early mortality following primary angioplasty for acute myocardial infarctionJeffrey S Berger
Division of Cardiovascular Medicine, Duke University School of Medicine, Durham, North Carolina, USA
Am J Cardiol 98:1140-3. 2006..In conclusion, female gender was found to be an independent predictor of in-hospital mortality in patients <75 years of age after primary angioplasty for AMI... - Improving the quality of care for women with cardiovascular disease: report of a DCRI Think Tank, March 8 to 9, 2007Jeffrey S Berger
Duke Clinical Research Institute and the Division of Cardiovascular Medicine, Duke University, Durham, NC 27715, USA
Am Heart J 156:816-25, 825.e1. 2008..Nevertheless, little attention has focused on improving the quality of healthcare in women compared with other areas of cardiovascular medicine... - Association of glycoprotein IIb/IIIa inhibitors and long-term survival following administration during percutaneous coronary intervention for acute myocardial infarctionJeffrey S Berger
Department of Medicine (Cardiovascular Medicine, Duke University, Durham, NC, USA
J Thromb Thrombolysis 21:229-34. 2006..159; 95% Confidence Interval, 0.034-0.729; P = 0.018). CONCLUSIONS: Treatment of patients undergoing PCI for AMI with GP IIb/IIIa antagonists appears to be associated with a profound reduction in late mortality... - Impact of left ventricular dysfunction on hospital mortality among patients undergoing elective percutaneous coronary interventionThomas W Wallace
Duke University Medical Center, Durham, NC, USA
Am J Cardiol 103:355-60. 2009..For patients who undergo elective PCI, an EF < or =45% is associated with higher adjusted hospital mortality. Whether elective PCI in patients with low EFs reduces morbidity and/or mortality over medical therapy alone is unknown... - Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trialsJonathan P Piccini
Division of Cardiology, Duke Clinical Research Institute, Duke University Medical Center 31115, Durham, NC 27710, USA
Eur Heart J 30:1245-53. 2009..There are conflicting data regarding the efficacy and safety of amiodarone for the prevention of SCD... - A clinician's perspective of emerging P2Y(12)-directed pharmacotherapies, ex vivo measurement tools, and clinical outcomesJeffrey S Berger
Division of Cardiology, Duke University School of Medicine and Duke Clinical Research Institute, Durham, NC 27715, USA
Platelets 20:302-15. 2009..Investigation of practical ex vivo platelet performance measurement tools is actively proceeding and may provide important information for patient management... - Impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes and long-term survival following percutaneous coronary rotational atherectomyJeffrey S Berger
Beth Israel Medical Center, New York, NY, USA
J Thromb Thrombolysis 19:47-54. 2005..These data do not indicate a significant association between GP IIb/IIIa inhibitor treatment during PCRA and MACE or survival... - Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trialsRichard Andraws
Cardiovascular Medicine, Department of Medicine, Beth Israel Medical Center, New York, NY, USA
JAMA 293:2641-7. 2005..2% vs 9.6%; OR, 0.91; 95% CI, 0.76-1.07; P = .25). CONCLUSION: Evidence available to date does not demonstrate an overall benefit of antibiotic therapy in reducing mortality or cardiovascular events in patients with CAD... - Comparison of outcomes in acute myocardial infarction treated with coronary angioplasty alone versus coronary stent implantationJeffrey S Berger
The Department of Medicine (Cardiovascular Medicine, State University of New York-Stony Brook School of Medicine, Stony Brook, New York
Am J Cardiol 97:977-80. 2006..474, 95% confidence interval 0.311 to 0.723, p = 0.001)... - Competency in electrocardiogram interpretation among internal medicine and emergency medicine residentsJeffrey S Berger
Department of Internal Medicine, Beth Israel Medical Center, New York, New York 10003, USA
Am J Med 118:873-80. 2005..Our study evaluated the ability of internal medicine residents and emergency medicine residents to interpret a variety of electrocardiograms... - Impact of gender on mortality following primary angioplasty for acute myocardial infarctionJeffrey S Berger
Department of Medicine (Cardiology, Beth Israel Medical Center, New York, NY 10003, USA
Prog Cardiovasc Dis 46:297-304. 2004